COMMUNIQUÉS West-GlobeNewswire

-
Digirad Announces Closing of Sale of its MDSS Service Contracts to Philips North America
02/02/2018 - 22:05 -
Cytokinetics to Announce Fourth Quarter Results on February 15, 2018
02/02/2018 - 22:00 -
Tauriga Sciences Inc. Takes Advantage of Market Weakness and Averages Down with Purchase of an Additional $10,000 USD Worth of Crypto Currency Groestlcoin
02/02/2018 - 18:13 -
Emblem Completes Bought Deal Financing
02/02/2018 - 18:08 -
SENS Research Foundation Receives $2.4 Million Ethereum Donation From Vitalik Buterin
02/02/2018 - 17:00 -
SENS Research Foundation Receives an Additional $1 Million Bitcoin Donation From Pineapple Fund
02/02/2018 - 17:00 -
Virbac : Declaration of the number of shares and voting rights as of January 2018, 31.
02/02/2018 - 16:29 -
Virbac : Déclaration d'actions et de droits de vote au 31 Janvier 2018
02/02/2018 - 16:29 -
Jørgen Erichsen, Executive Vice President, Natural Colors Division, to leave Chr. Hansen Holding A/S
02/02/2018 - 16:01 -
Appointment of Jonathan E. Gold as Interim Chief Financial Officer
02/02/2018 - 16:00 -
TESARO to Announce Fourth-Quarter 2017 Financial Results on February 27, 2018
02/02/2018 - 15:48 -
Trading in Novo Nordisk shares by board members, executives and associated persons on 1 February 2018
02/02/2018 - 15:40 -
Knalysis Technologies is On the Move
02/02/2018 - 15:19 -
Cambrex to Announce Fourth Quarter and Full Year 2017 Financial Results on February 8, 2018
02/02/2018 - 15:15 -
Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium
02/02/2018 - 14:54 -
Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Epigenetics Research Conference
02/02/2018 - 14:30 -
Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT
02/02/2018 - 14:30 -
Sorrento Therapeutics CEO Dr Ji to Present at LEERINK Partners 7th Global Healthcare Conference on 02/15/18
02/02/2018 - 14:00 -
Aclaris Therapeutics to Attend Upcoming Investor Conferences
02/02/2018 - 14:00
Pages